Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...
Egile Nagusiak: | Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium |
---|---|
Formatua: | Journal article |
Argitaratua: |
Company of Biologists
2017
|
Antzeko izenburuak
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
nork: Bowerman, M, et al.
Argitaratua: (2017) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
nork: Melissa Bowerman, et al.
Argitaratua: (2017-08-01) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
nork: Winkelsas, AM, et al.
Argitaratua: (2021) -
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
nork: Audrey M. Winkelsas, et al.
Argitaratua: (2021-03-01) -
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
nork: Wishart, T, et al.
Argitaratua: (2010)